US Broker Ratings

Novo Nordisk A/S (NVO) Stock Analysis: Navigating Growth and Challenges in the Healthcare Sector

Novo Nordisk A/S (NYSE: NVO) stands as a prominent player in the healthcare sector, particularly within the drug manufacturing industry. With a commanding market capitalization of $218.94 billion, this Denmark-based..

Illumina, Inc. (ILMN) Stock Analysis: Understanding the 33.82% Return on Equity in a Challenging Market

In the ever-evolving landscape of healthcare and diagnostics, Illumina, Inc. (NASDAQ: ILMN) stands as a pivotal player with its cutting-edge genomic solutions. Focused on genetic and genomic analysis, Illumina provides..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Strong Analyst Consensus and a 10% Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV) stands as a titan in the healthcare sector, specifically within the diagnostics and research industry. With a substantial market capitalization of $34.69 billion, the company..

Haleon plc (HLN) Stock Analysis: Unveiling 19.36% Potential Upside in the Healthcare Sector

Haleon plc (HLN), a distinguished player in the healthcare sector, continues to capture investor attention with its robust portfolio of consumer healthcare products. Operating within the Drug Manufacturers – Specialty..

Abbott Laboratories (ABT) Stock Analysis: Exploring a 23.92% Potential Upside in the Healthcare Giant

Abbott Laboratories (NYSE: ABT) stands as a formidable player in the healthcare sector, with a market cap of $163.61 billion. This American medical devices titan has made significant strides in..

Edwards Lifesciences Corporation (EW) Stock Analysis: A Healthcare Leader with a Promising 6.2% Upside

Edwards Lifesciences Corporation (NYSE: EW), a titan in the medical devices industry, is making waves in the healthcare sector with its innovative cardiovascular solutions. With a market capitalization of $53.09..

Elevance Health, Inc. (ELV) Stock Analysis: Navigating Opportunities in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), previously known as Anthem, Inc., is a key player in the healthcare sector with a market capitalization of $90.39 billion. As healthcare continues to be..

Insulet Corporation (PODD) Stock Analysis: Strong Buy Ratings and Nearly 48% Upside Potential

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector, particularly within the medical devices industry, stands out with a market capitalization of $11.17 billion. Headquartered in Acton, Massachusetts,..

Merck & Company, Inc. (MRK) Stock Analysis: Evaluating Growth Potential and 7.12% Upside

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, is a key player in the pharmaceutical industry with a market capitalization of $305.12 billion. As an investor,..

Novartis AG (NVS) Stock Analysis: Evaluating Its 0.33% Potential Upside Amidst Strong ROE and Dividend Yield

Investors eyeing the healthcare sector often consider Novartis AG (NVS), a Swiss pharmaceutical giant with a market cap of $293.94 billion. As a key player in the drug manufacturing industry,..

Quest Diagnostics (DGX) Stock Analysis: Uncovering a 7.83% Upside Potential

Quest Diagnostics Incorporated (NYSE: DGX), a leader in the U.S. healthcare diagnostics and research industry, presents a compelling investment opportunity with its solid fundamentals and promising growth prospects. As a..

HCA Healthcare (HCA) Stock Analysis: Capitalizing on a 21.38% Potential Upside

HCA Healthcare, Inc. (NYSE: HCA) stands as a significant player in the U.S. healthcare sector, boasting a market capitalization of $90.2 billion. As a leading provider of a broad spectrum..

UnitedHealth Group (UNH) Stock Analysis: Evaluating Market Position Amidst Stable Dividend Yield

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, operates primarily within the healthcare plans industry. With a substantial market capitalization of $385.62 billion, UnitedHealth Group stands as..

The Cigna Group (CI) Stock Analysis: Exploring a Potential 16% Upside for Healthcare Investors

The Cigna Group (NYSE: CI) stands as a prominent entity in the healthcare sector, with a robust market capitalization of $77.63 billion. Notably, the company operates in the healthcare plans..

Mettler-Toledo International (MTD) Stock Analysis: Potential Upside and Strategic Positioning in Diagnostics & Research

Mettler-Toledo International Inc. (NYSE: MTD), a prominent player in the diagnostics and research sector, presents a compelling opportunity for investors with its diverse portfolio of precision instruments and a strategic..

IDEXX Laboratories, Inc. (IDXX)

⚠️ No article content returned.

..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A Strong Buy Opportunity with 47% Upside Potential

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) sits at the forefront of the biotechnology sector, specializing in the groundbreaking field of ribonucleic acid interference (RNAi) therapeutics. With a market capitalization of $39.89..

Stryker Corporation (SYK) Stock Analysis: Unpacking a 17% Potential Upside Amid Robust Market Position

Stryker Corporation (NYSE: SYK) stands as a healthcare titan within the medical devices industry, boasting a formidable market capitalization of $126.42 billion. As a key player in both MedSurg &..

GSK plc (GSK) Stock Analysis: Evaluating the 7.51% Upside Potential in the Healthcare Giant

As one of the stalwarts in the healthcare sector, GSK plc (NYSE: GSK) presents a compelling opportunity for investors looking to capitalize on its strong market position and promising upside..

Sanofi (SNY) Stock Analysis: Discover a Potential 26.56% Upside in the Healthcare Giant

Sanofi (SNY), the Paris-based healthcare titan, stands as a formidable player in the drug manufacturing industry with a market capitalization of $104.13 billion. As an investor focusing on the healthcare..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds